Search research articles
Contact Us
Filters
Showing results (131-140 of 138) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 138 results.
Neurology. Genetics
|
August 19, 2016
Pathogenic mtDNA mutations causing mitochondrial myopathy: The need for muscle biopsy
Steven A Hardy, Emma L Blakely, Andrew I Purvis, et al.
Physiological and Biochemical Zoology : PBZ
|
June 6, 2023
Building Bridges from Genome to Physiology Using Machine Learning and
James N Kezos, Thomas T Barter, Mark A Phillips, et al.
Brain : a Journal of Neurology
|
May 8, 2007
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies
Haiyan Zhou, Heinz Jungbluth, Caroline A Sewry, et al.
Neuromuscular Disorders : NMD
|
January 19, 2010
Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene
Haiyan Zhou, Suzanne Lillis, Ryan E Loy, et al.
Physiological and Biochemical Zoology : PBZ
|
October 12, 2019
Genomics of Early Cardiac Dysfunction and Mortality in Obese <i>Drosophila melanogaster</i>
James N Kezos, Mark A Phillips, Misty D Thomas, et al.
The Lancet. Infectious Diseases
|
June 11, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
Carolyn T Bramante, John B Buse, David M Liebovitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2024
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19
Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial
Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 138) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 138 results.
Neurology. Genetics
|
August 19, 2016
Pathogenic mtDNA mutations causing mitochondrial myopathy: The need for muscle biopsy
Steven A Hardy, Emma L Blakely, Andrew I Purvis, et al.
Physiological and Biochemical Zoology : PBZ
|
June 6, 2023
Building Bridges from Genome to Physiology Using Machine Learning and
James N Kezos, Thomas T Barter, Mark A Phillips, et al.
Brain : a Journal of Neurology
|
May 8, 2007
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies
Haiyan Zhou, Heinz Jungbluth, Caroline A Sewry, et al.
Neuromuscular Disorders : NMD
|
January 19, 2010
Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene
Haiyan Zhou, Suzanne Lillis, Ryan E Loy, et al.
Physiological and Biochemical Zoology : PBZ
|
October 12, 2019
Genomics of Early Cardiac Dysfunction and Mortality in Obese <i>Drosophila melanogaster</i>
James N Kezos, Mark A Phillips, Misty D Thomas, et al.
The Lancet. Infectious Diseases
|
June 11, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
Carolyn T Bramante, John B Buse, David M Liebovitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2024
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19
Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial
Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Page
of 14